Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Japanese approval of additional indication for Riona

March 25, 2021

Kinase links innate immunity to MDS

March 24, 2021

Biotest presents FVIII-based recombinant proteins for hemophilia A

March 24, 2021

BioCryst presents successful data from proof-of-concept trial of BCX-9930 in PNH

March 23, 2021

Cellphire initiates phase II study of Thrombosomes for bleeding in patients with thrombocytopenia

March 22, 2021

New results presented for oral formulation of milvexian

March 18, 2021

KalVista Pharmaceuticals discovers FXIIa inhibitors

March 17, 2021

Dosing begins in first-in-human study of CAN-106 for complement dysregulation diseases

March 10, 2021

PHA-022121 shows promise for treating hereditary angioedema

March 4, 2021

FDA accepts IND application for EP-7041 for thrombosis prevention in patients with COVID-19

March 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...